177Lu-LNC1011
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 177Lu-LNC1011, covering 2024-12-11 to 2025-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer [NA]